生命科学资讯

Biggest gainers and losers for Feb. 2-6, 2026

Venenum Biodesign discloses new MOGAT2 inhibitors

Korean researchers report new HER1/HER2 mutant inhibitors

Hansoh Pharma and Hansoh Bio synthesize new muscarinic M4 receptor agonists

Idorsia gets FDA-backed route to approval for oral Fabry drug

More biopharma IPOs: Agomab raises $200M, Spyglass gets $150M

Bayer’s asundexian cuts stroke risk 26% in phase III win

Money raised by biopharma

Biopharma money raised: Jan. 1-Feb. 5, 2026

BioWorld and Nasdaq stock indices

Biopharma money raised by month in 2026 (US$M)

Trump’s drug-discount website goes live

ALTx formed to drug pathway by which cancer cells become immortal

O-GlcNAcase inhibitors reported in Tyk Medicines patent

Abbisko Therapeutics identifies GTPase KRAS mutant inhibitors

Shenzhen Salubris Pharmaceuticals synthesizes dual PCSK9/HMG-CoA reductase inhibitors

Appointments and advancements for Feb. 5, 2026

Financings for Feb. 5, 2026

In the clinic for Feb. 5, 2026

Other news to note for Feb. 5, 2026